Cingulate Inc. Warrants Share Price
CINGWCingulate Inc. Warrants Stock Performance
Open $0.05 | Prev. Close $0.05 | Circuit Range N/A |
Day Range $0.05 - $0.05 | Year Range $0.03 - $0.09 | Volume 745 |
Average Traded $0.05 |
Cingulate Inc. Warrants Share Price Chart
About Cingulate Inc. Warrants
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmacology and Phase 3 clinical efficacy and safety trials for the treatment of ADHD in children, adolescents, and adults; and CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and related disorders. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Cingulate Inc. Warrants Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Jan-26 | $0.05 | $0.05 | -37.50% |
15-Dec-25 | $0.08 | $0.08 | +60.00% |
14-Oct-25 | $0.05 | $0.05 | +0.00% |
28-Aug-25 | $0.05 | $0.05 | -21.88% |
22-Aug-25 | $0.06 | $0.06 | +0.00% |
21-Aug-25 | $0.06 | $0.06 | +0.00% |
20-Aug-25 | $0.06 | $0.06 | +0.00% |